The FDA has approved a new therapeutic use for a widely-used diabetes medication, expanding treatment options for patients. This approval marks a significant development in diabetes care, offering physicians additional tools to manage the condition. The expanded indication reflects ongoing research into the drug’s broader health benefits and potential applications beyond its original approved use.